Related articles
Read more
Yes, pregnancy is possible during perimenopause, but not usually through natural conception after confirmed menopause. IVF using donor eggs or previously frozen eggs or embryos may make pregnancy possible for some women after menopause. Whether you can carry the pregnancy yourself depends on your health and uterine condition. If pregnancy would be medically unsafe, gestational surrogacy may be another option.
The best approach depends on your individual circumstances, not age alone.
Yes. Natural pregnancy is still possible during perimenopause because ovulation may continue, even when periods become irregular.
Perimenopause is the transition leading up to menopause. Hormone levels fluctuate during this time. You may skip periods for several months, then ovulate unexpectedly.
Fertility declines with age as the number and quality of eggs decrease. Pregnancy becomes less likely, but irregular periods do not mean that pregnancy is impossible.
If you do not want to become pregnant, continue using contraception until a healthcare professional confirms when you can safely stop. The timing depends on your age, menstrual history, and contraception method.
Natural pregnancy is not expected after confirmed natural menopause. However, assisted reproductive treatment may make pregnancy possible.
Menopause is usually defined as 12 consecutive months without a menstrual period when no other cause explains the absence of periods.
After natural menopause, the ovaries generally no longer release eggs capable of supporting natural conception. But the end of ovarian function does not automatically mean the uterus can no longer carry a pregnancy.
There are two separate questions:
IVF with donor eggs or previously frozen eggs or embryos may be considered for selected patients. If carrying a pregnancy would pose a serious health risk, a gestational carrier may be an alternative.
Yes. IVF using donor eggs is an established treatment option for some postmenopausal women. However, treatment is not suitable for everyone and does not guarantee a successful birth.
Three approaches may be considered.
A donor egg is fertilized with sperm in a laboratory. The resulting embryo may then be transferred into the intended mother’s uterus if she is medically suitable to carry a pregnancy.
The child has a genetic connection to the egg donor and to the person who provided the sperm. The intended mother does not have a genetic connection through the donated egg, but she may carry and give birth to the child.
Hormone treatment may be used to prepare the uterine lining before embryo transfer. A fertility specialist must assess whether this approach is appropriate.
If you froze eggs before menopause, they may still be available for IVF. The eggs can be fertilized in a laboratory, and an embryo may be transferred if the medical team considers pregnancy appropriate.
If you already have frozen embryos, your clinic can assess whether they are suitable for transfer.
The age at which the eggs were retrieved matters when estimating their reproductive potential. Your current age and health also matter when assessing the safety of carrying a pregnancy.
A gestational carrier carries an embryo created using eggs and sperm from the intended parents, donors, or a combination of these sources.
When the carrier does not provide the egg, she has no genetic connection to the child.
This option may be considered when the intended mother does not have a uterus, cannot safely carry a pregnancy, or has a medical condition that makes pregnancy especially risky.
Donor eggs can make pregnancy possible after age 50, but success is not guaranteed. The age and health of the person carrying the pregnancy also matter.
A study published in JAMA in 2002 examined 77 selected postmenopausal women aged 50–63 who underwent IVF using donor eggs. The researchers reported a clinical pregnancy rate of 45.5% and a live birth rate of 37.2% per embryo transfer.
The study also reported pregnancy complications, including preeclampsia and gestational diabetes.
These findings are historical and come from a small, selected group. They should not be treated as current success rates or as a prediction of an individual’s chances.
Research also suggests that the recipient’s age may affect outcomes even when donor eggs are used.
A 2026 study examined 2,760 single-blastocyst transfers in 1,774 women receiving donor eggs. Among recipients aged 49 and older, the live birth rate per transfer was 31.7%, compared with 46.2% among recipients aged 35–40. The miscarriage rate was 37.6% in the older group and 24.2% in the younger group.
This was an observational study. It cannot prove that uterine ageing alone caused the differences, and the results do not predict what will happen to every patient.
The practical point is that donor egg quality is not the only factor affecting success. The recipient’s age, uterine condition, general health, and pregnancy risks also matter.
Ask your clinic to explain its own success rates, how those rates are calculated, and how your medical history affects your treatment plan.
Pregnancy after menopause may be possible, but it can carry substantial medical risks, particularly at older ages.
Using donor eggs does not remove the risks associated with the age and medical condition of the person carrying the pregnancy.
Potential complications include:
The level of risk varies between individuals. Age alone cannot determine whether pregnancy is medically appropriate.
Before treatment, a specialist may assess blood pressure, cardiovascular health, diabetes risk, uterine health, medications, and other medical conditions. A high-risk obstetrician may also need to be involved.
Neither option is automatically better for everyone. The decision should be based on an individual medical assessment.
Some postmenopausal women may be able to carry a pregnancy after IVF with donor eggs, provided their health and uterine condition allow it. For others, pregnancy may be medically unsafe or impossible, making gestational surrogacy an alternative.
| Consideration | Carrying the Pregnancy Yourself | Gestational Surrogacy |
|---|---|---|
| Where the pregnancy develops | Your uterus | The carrier's uterus |
| Possible egg source | Donor eggs or previously frozen eggs | Donor eggs, previously frozen eggs, or another suitable source |
| Pregnancy-related physical risks to you | You experience the risks of pregnancy | You avoid the physical risks of carrying the pregnancy |
| Medical assessment | Needed before treatment and pregnancy | Needed for the intended parents, carrier, and embryo plan |
| Legal requirements | Depend on treatment and location | Surrogacy and parentage laws must be checked carefully |
A fertility specialist can assess whether you are medically fit to carry a pregnancy. A high-risk obstetrician may also need to review your health before treatment.
The American Society for Reproductive Medicine recommends considering a gestational carrier when a medical condition prevents someone from carrying a pregnancy or makes pregnancy a significant risk to the woman or fetus.
Surrogacy can avoid the physical risks of pregnancy for the intended mother. However, it involves separate medical, legal, financial, and emotional considerations. It does not guarantee a successful birth or remove every risk.
The goal is not to choose surrogacy over IVF in every case. It is to identify the safest and most appropriate path to parenthood for each person.
Sometimes. Menopause ends normal ovarian function, but it does not automatically make the uterus unable to carry a pregnancy.
In selected patients, hormone treatment may prepare the uterine lining for embryo transfer. The uterus and the person’s overall health must be assessed before treatment.
Two widely reported cases illustrate what has been medically possible:
These cases show that pregnancy after menopause has occurred with medical assistance. They are exceptional examples, not evidence that pregnancy at these ages is generally safe or available.
Most fertility programs apply age and health criteria to gestational carriers. Requirements vary by clinic and jurisdiction.
There is currently no proven treatment that reliably reverses natural menopause and restores normal fertility.
Several treatments are promoted as ways to rejuvenate the ovaries, including platelet-rich plasma (PRP) injections and stem cell therapy. These approaches remain experimental for fertility treatment.
PRP involves injecting a preparation made from a person’s own blood into the ovaries. Researchers have investigated whether it can affect ovarian activity in people with fertility problems.
The findings are not consistent, and studies have examined different patient groups. Results from people with poor ovarian response cannot automatically be applied to people with premature ovarian insufficiency (POI), much less to natural menopause.
A 2024 randomized trial involving patients with poor ovarian response reported that PRP did not improve the quality of the resulting blastocysts. Other research has investigated PRP in people with POI, but evidence of follicular activity does not prove that a treatment restores normal fertility or increases the chance of a live birth.
PRP is not an established treatment for reversing natural menopause. More high-quality research is needed to determine whether it offers meaningful fertility benefits in specific patient groups.
Researchers are also investigating immunotherapy for a specific group: people with autoimmune premature ovarian insufficiency, in which an autoimmune process is believed to contribute to ovarian dysfunction.
A small proof-of-concept study investigated rituximab in this group and reported signs of renewed follicular activity in some participants. However, the study was small and had no control group.
These findings are experimental. Rituximab is not an established fertility treatment for POI, and this research does not show that immunotherapy can reverse natural menopause. It should not be considered a routine treatment option for the general public.
POI is different from natural menopause. In POI, ovarian activity may sometimes fluctuate, and occasional spontaneous ovulation may occur. This does not mean that established natural menopause can reliably be reversed.
For people who want to pursue pregnancy after natural menopause, IVF using donor eggs remains an established option for selected patients. A fertility specialist can assess whether carrying the pregnancy is medically appropriate or whether a gestational carrier should be considered.
Menopause usually occurs between ages 45 and 55. Premature ovarian insufficiency (POI) refers to impaired ovarian function before age 40.
POI can cause irregular or absent periods and lower estrogen levels. Unlike typical natural menopause, ovarian activity may occasionally return, so spontaneous pregnancy is possible in some cases, although it is uncommon and unpredictable.
No treatment has been proven to restore ovarian activity and natural fertility reliably in everyone with POI. Donor eggs are an established fertility option for those who want to pursue pregnancy.
If your periods stop before age 40, seek medical evaluation. Do not assume that the cause is menopause without assessment.
IVF has not been shown to cause early menopause simply because it stimulates the ovaries.
During ovarian stimulation, medication encourages several follicles to develop. These eggs generally come from the group of follicles that would otherwise be lost during that cycle.
People who need IVF may already have low ovarian reserve or another condition associated with earlier ovarian ageing. These underlying factors can make it seem as though IVF caused the problem.
If you experience irregular periods or menopausal symptoms after fertility treatment, discuss them with your clinician rather than assuming IVF caused early menopause.
Menopause and early pregnancy can cause overlapping symptoms, including fatigue, breast tenderness, mood changes, and changes in menstrual patterns.
| Symptom or Sign | What It May Mean |
|---|---|
| Irregular or missed periods | May occur during perimenopause or pregnancy |
| Hot flashes and night sweats | Common during the menopausal transition |
| Nausea | Can occur in pregnancy but does not confirm it |
| Breast tenderness | Can occur with pregnancy or hormonal changes |
| Positive pregnancy test | Strong evidence of pregnancy when used correctly |
Symptoms alone cannot reliably distinguish pregnancy from perimenopause.
If pregnancy is possible, take a home pregnancy test according to its instructions. If the result is negative but pregnancy remains possible, repeat the test after a few days or contact a healthcare professional.
A blood test or other assessment may be needed. Hormone tests are not a substitute for a pregnancy test, and a single FSH result does not always establish menopause.
Seek prompt medical care for bleeding after menopause. There are several possible causes, but postmenopausal bleeding needs evaluation. If you have a positive pregnancy test with severe abdominal pain, fainting, or heavy bleeding, seek urgent medical care.
Seek medical advice early if you:
People over 40 who want to conceive should generally seek an early fertility assessment rather than waiting many months before asking for help.
A consultation can help clarify whether you may use your own frozen eggs or embryos, need donor eggs, can safely carry a pregnancy, or should consider a gestational carrier.
For people who cannot safely carry a pregnancy, gestational surrogacy may offer another route to parenthood.
The process generally involves:
VITA Surrogacy can help intended parents explore their options and understand the medical and practical steps involved. Eligibility, treatment availability, costs, and legal parentage must be confirmed for each case.
Contact VITA Surrogacy to discuss whether gestational surrogacy may fit your circumstances.
